Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
A review of 606 trial abstracts on diabetic foot reveals persistent gaps in reporting essential research details, despite the publication of reporting guidelines like CONSORT-A, highlighting ongoing challenges in research transparency and clarity. A new review published by MDPI’s journal…
A recent study from South India indicates that music therapy could become a valuable addition to standard care for managing diabetes-related distress and physiological health, with significant benefits observed over a 21-day period. A study from a tertiary care hospital…
A new study from the University of Pennsylvania reveals that patients using GLP-1 medications like Wegovy and Ozempic for diabetes and weight management face a heightened risk of hair loss, prompting further investigation into potential side effects amid expanding use.…
In Bangladesh, a pioneering programme involving mosques and religious leaders aims to curb the surging diabetes epidemic by integrating health advice with faith and community engagement, with plans to extend its reach to other religious groups and promote international cooperation.…
Eledon Pharmaceuticals has filed a US regulatory application for a company-led study of tegoprubart in type 1 diabetes patients undergoing islet cell transplants, as it pushes forward multiple transplant programmes and a broad kidney trial scheduled for late 2026. Eledon…
New Australian research highlights that adults combining moderate aerobic activity with muscle-strengthening exercises dramatically cut their likelihood of developing type 2 diabetes, emphasising the importance of varied exercise routines beyond walking alone. A growing body of research suggests that people…
New research from Queen Mary University of London highlights significant differences in mental health and cardiovascular risks for women and men following a type 2 diabetes diagnosis, calling for more personalised care approaches. A UK study published in PLOS Medicine…
A Yale-led study finds GLP-1 receptor agonists may lower insulin use in some type 2 diabetes patients but do not significantly increase the likelihood of stopping insulin entirely, highlighting ongoing challenges in medication management. A Yale-led study has found that…
Regulators increase scrutiny over the import, labelling, and safety of compounded GLP-1 weight-loss drugs, warning of counterfeit products and dangerous ingredients in circulation across the US and globally. Federal regulators have moved to tighten control over the ingredients used in…
A guide to understanding macronutrients and meal planning that can help you adopt a flexible diet without costly specialised products, emphasising practicality and personalised adjustments. Changing the way you eat can be expensive if the first thing you do is…
Researchers uncover how distinct brain regions mediate the effects of GIPR agonists and antagonists on appetite and weight loss, paving the way for more personalised obesity therapies. Researchers have identified two separate brain circuits that help explain why both stimulating…
Emerging research underscores the importance of integrating brisk walking with strength training for improved blood glucose control among pre-diabetic individuals, with practical advice on how to tailor routines effectively. For people with pre-diabetes, the choice between brisk walking and strength…
